FilingSEC EDGAR8-K
Heron Therapeutics Enters into Development and License Agreement with Long Grove
· SEC accepted
StageAgreement Signed
Filing content
Heron Therapeutics entered into a license agreement with Long Grove Pharmaceuticals to obtain exclusive rights to import, distribute, and market certain products in the United States.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…